TY - JOUR
T1 - Talin1 dysfunction is genetically linked to systemic capillary leak syndrome
AU - Elefant, Naama
AU - Rouni, Georgia
AU - Arapatzi, Christina
AU - Oz-Levi, Danit
AU - Sion-Sarid, Racheli
AU - Edwards, William J.S.
AU - Ball, Neil J.
AU - Yanovsky-Dagan, Shira
AU - Cowell, Alana R.
AU - Meiner, Vardiella
AU - Vainstein, Vladimir
AU - Grammenoudi, Sofia
AU - Lancet, Doron
AU - Goult, Benjamin T.
AU - Harel, Tamar
AU - Kostourou, Vassiliki
N1 - Publisher Copyright:
© 2024, Elefant et.
PY - 2024/12/20
Y1 - 2024/12/20
N2 - Systemic capillary leak syndrome (SCLS) is a rare life-threatening disorder due to profound vascular leak. The trigger and the cause of the disease are currently unknown and there is no specific treatment. Here, we identified a rare heterozygous splice-site variant in the TLN1 gene in a familial SCLS case, suggestive of autosomal dominant inheritance with incomplete penetrance. Talin1 has a key role in cell adhesion by activating and linking integrins to the actin cytoskeleton. This variant causes in-frame skipping of exon 54 and is predicted to affect talin’s C-terminal actin-binding site (ABS3). Modeling the SCLS-TLN1 variant in TLN1-heterozygous endothelial cells (ECs) disturbed the endothelial barrier function. Similarly, mimicking the predicted actin-binding disruption in TLN1-heterozygous ECs resulted in disorganized endothelial adherens junctions. Mechanistically, we established that the SCLS-TLN1 variant, through the disruption of talin’s ABS3, sequestrates talin’s interacting partner, vinculin, at cell–extracellular matrix adhesions, leading to destabilization of the endothelial barrier. We propose that pathogenic variants in TLN1 underlie SCLS, providing insight into the molecular mechanism of the disease that can be explored for future therapeutic interventions.
AB - Systemic capillary leak syndrome (SCLS) is a rare life-threatening disorder due to profound vascular leak. The trigger and the cause of the disease are currently unknown and there is no specific treatment. Here, we identified a rare heterozygous splice-site variant in the TLN1 gene in a familial SCLS case, suggestive of autosomal dominant inheritance with incomplete penetrance. Talin1 has a key role in cell adhesion by activating and linking integrins to the actin cytoskeleton. This variant causes in-frame skipping of exon 54 and is predicted to affect talin’s C-terminal actin-binding site (ABS3). Modeling the SCLS-TLN1 variant in TLN1-heterozygous endothelial cells (ECs) disturbed the endothelial barrier function. Similarly, mimicking the predicted actin-binding disruption in TLN1-heterozygous ECs resulted in disorganized endothelial adherens junctions. Mechanistically, we established that the SCLS-TLN1 variant, through the disruption of talin’s ABS3, sequestrates talin’s interacting partner, vinculin, at cell–extracellular matrix adhesions, leading to destabilization of the endothelial barrier. We propose that pathogenic variants in TLN1 underlie SCLS, providing insight into the molecular mechanism of the disease that can be explored for future therapeutic interventions.
UR - https://www.scopus.com/pages/publications/85212837012
U2 - 10.1172/jci.insight.173664
DO - 10.1172/jci.insight.173664
M3 - Article
C2 - 39704176
AN - SCOPUS:85212837012
SN - 2379-3708
VL - 9
JO - JCI Insight
JF - JCI Insight
IS - 24
M1 - e173664
ER -